A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients

Abstract Introduction: Racial and ethnic minority groups have higher rates of SARS-CoV-2 infection, severe illness, and death; however, they receive monoclonal antibody (mAb) treatment at lower rates than non-Hispanic White patients. We report data from a systematic approach to improve equitable p...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Lindsey E. Fish, Tiffany Bendelow, Sarah Gardiner, Matthew K. Wynia, Bethany M. Kwan, Mika K. Hamer, Adit A. Ginde, Rebecca Hanratty
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Cambridge University Press 2023-01-01
Rangatū:	Journal of Clinical and Translational Science
Ngā marau:	SARS-CoV-2 monoclonal antibodies health equity COVID-19 race/ethnic disparity community-based
Urunga tuihono:	https://www.cambridge.org/core/product/identifier/S205986612200526X/type/journal_article
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!